Bupivacaine/meloxicam
Bupivacaine/meloxicam, sold under the brand name Zynrelef, is a fixed-dose combination medication used to treat pain in small to medium-sized wounds after surgery.[1] It contains bupivacaine and meloxicam.[1]
| Combination of | |
|---|---|
| Bupivacaine | Local anesthetic |
| Meloxicam | Nonsteroidal anti-inflammatory drug (NSAID) |
| Clinical data | |
| Trade names | Zynrelef |
| License data | |
| Routes of administration | Intralesional |
| ATC code | |
| Legal status | |
| Legal status |
|
It was approved for medical use in the European Union in September 2020.[1]
References
- "Zynrelef EPAR". European Medicines Agency (EMA). 22 July 2020. Retrieved 6 October 2020.
External links
- "Bupivacaine". Drug Information Portal. U.S. National Library of Medicine.
- "Meloxicam". Drug Information Portal. U.S. National Library of Medicine.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.